BlackRock Investment Management, LLC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 37 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$6,000
-33.3%
6,8690.0%0.00%
Q3 2016$9,000
-25.0%
6,8690.0%0.00%
Q2 2016$12,000
+9.1%
6,869
+19.4%
0.00%
Q1 2016$11,000
-42.1%
5,7550.0%0.00%
Q4 2015$19,000
+111.1%
5,755
+9.3%
0.00%
Q3 2015$9,000
-30.8%
5,267
+5.4%
0.00%
Q2 2015$13,000
-92.9%
4,998
-93.2%
0.00%
Q1 2015$182,000
-49.2%
73,717
+21.3%
0.00%
Q4 2014$358,000
-11.8%
60,770
+0.2%
0.00%
-100.0%
Q3 2014$406,000
+1.5%
60,626
+9.4%
0.00%0.0%
Q2 2014$400,00055,4020.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 8,343,716$2,053,0002.58%
Sio Capital Management, LLC 4,935,250$1,214,0000.29%
Endurant Capital Management LP 2,481,355$610,0000.24%
Fosun International Ltd 596,752$147,0000.01%
Malaga Cove Capital, LLC 30,000$7,0000.01%
Summit X, LLC 35,000$8,0000.00%
ARDSLEY ADVISORY PARTNERS LP 75,000$19,0000.00%
Fosun International Ltd 168,851$42,0000.00%
INTRUST BANK NA 40,000$10,0000.00%
Cetera Advisor Networks LLC 142,500$49,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders